ELLEN R JACOBSON

Allopathic & Osteopathic Physicians|Dermatology NASHVILLE, TN NPI 1962456772

General Payments — all program years on this page

$4,380.42

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 204
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $627.46 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $527.4720
Education $99.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $928.0148
2019 $505.4327
2020 $143.509
2021 $394.8419
2022 $631.2523
2023 $1,149.9357
2024 $627.4621

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078672935 Janssen Biotech, Inc. $99.99 04/08/2024 Education Undisputed 01/23/2026 View at CMS
1101466711 E.R. Squibb & Sons, L.L.C. $14.49 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101466722 E.R. Squibb & Sons, L.L.C. $16.82 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101466733 E.R. Squibb & Sons, L.L.C. $15.63 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103980492 ABBVIE INC. $20.44 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103980494 ABBVIE INC. $19.10 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103980496 ABBVIE INC. $22.01 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103980498 ABBVIE INC. $18.50 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114076006 Regeneron Healthcare Solutions, Inc. $20.16 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114076008 Regeneron Healthcare Solutions, Inc. $118.24 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127883724 Dermavant Sciences, Inc. $16.40 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127883728 Dermavant Sciences, Inc. $17.99 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131455737 PFIZER INC. $16.01 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131510445 PFIZER INC. $17.37 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131575802 PFIZER INC. $21.25 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136161559 Lilly USA, LLC $20.43 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136174484 Lilly USA, LLC $22.19 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139621011 GENZYME CORPORATION $19.56 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145306233 Galderma Laboratories, L.P. $65.35 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152146731 SUN PHARMACEUTICAL INDUSTRIES INC. $19.29 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152636167 LEO Pharma Inc. $26.24 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.